The University of Oxford has launched the first study to assess the safety and immune responses in children and young adults of its coronavirus vaccine. The university said that previous trials of......
Backing the 12-16 weeks gap between the two doses of Covishield in the country, the chief investigator of the AstraZeneca vaccine clinical trials on Friday said that the level of protection......
The coronavirus vaccine developed by Oxford University and AstraZeneca shows promise as it can generate both antibodies and cell-mediated immune responses, say several scientists in India and......
A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent......
26 years after the first HIV+ case in Tamil Nadu, patients continue to be shunned and discriminated against. Shobha Warrier brings you the plight of such women from across the state. It was in......